Departments and Services | For Patients | Research & Trials | Education | Find a Doctor

Division of Infectious Disease
Division of Infections Disease
Fellowship Program
Clinical Programs
Penn CDC Prevention Epicenters Program
Clinical Trials
Botswana-UPenn Partnership
Adjunct Faculty
Administrative Contacts
Outpatient Clinics


faculty photo

Karam C. Mounzer, MD

Clinical Associate Professor of Medicine
Attending Physician, Penn Presbyterian Medical Center
Department: Medicine

Contact information
Philadelphia Fight, 1233 Locust Street
Philadelphia, PA 19107
Office: 215-790-1788
Fax: 215-732-5490
Bachelor (Experimental Sciences and French Literature)
College Notre Dame de Jamhour, Beirut, Lebanon, 1985.
MD (Pre-Med & Med combined)
Saint Joseph University, Faculty of Medicine, Beirut, Lebanon , 1992.
Post-Graduate Training
Internal Medicine, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, 1992-1993.
Residency, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School , 1993-1995.
Infectious Diseases Fellowship, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School , 1995-1997.
Diplomate, American Board of Internal Medicine , 1995.
Diplomate, American Board of Infectious Diseases , 1997.
Permanent link
> Perelman School of Medicine   > Faculty   > Details

Description of Research Expertise

Clinical Development of new antiretroviral agents

Description of Clinical Expertise

Treatment of Multi drug Resistant HIV virus, HIV-HCV co-infection

Description of Other Expertise

Suboxone Clinic for HIV infected opioid-addicted patients

Selected Publications

Papasavvas E, King G, Azzoni L, Aberra F, Tebas P, Mounzer K, Kostman JR, Richman D, Li Q, Montaner LJ: Reduced rectal HIV RNA after Peg-IFN-a2b added to ART together with ART interruption. 2016 Annual Conference on Retroviruses and Opportunistic Infections (CROI), Boston, MA 2016 Notes: Poster presentation.

Yehia BR, Mody A, Stewart L, Holtzman CW, Jacobs LM, Hines J, Mounzer K, Glanz K, Metlay JP, Shea JA: Impact of the Outpatient Clinic Experience on Retention in Care: Perspectives of HIV-Infected Patients and Their Providers. AIDS Patient Care STDS Page: 365-369, July 2015

Lo Re V 3rd, Lynn K, Stumm ER, Long J, Nezamzadeh MS, Baker JF, Hoofnagle AN, Kapalko AJ, Mounzer K, Zemel BS, Tebas P, Kostman JR, Leonard MB: Structural Bone Deficits in HIV/HCV-Coinfected, HCV-Monoinfected, and HIV-Monoinfected Women. J Infect Dis 212(6): 924-933, September 2015.

Naggie S, Cooper C, Saag M, Workowski K, Ruane P, Towner WJ, Marks K, Luetkemeyer A, Baden RP, Sax PE, Gane E, Santana-Bagur J, Stamm LM, Yang JC, German P, Dvory-Sobol H, Ni L, Pang PS, McHutchison JG, Stedman CA, Morales-Ramirez JO, Bräu N, Jayaweera D, Colson AE, Tebas P, Wong DK, Dieterich D, Sulkowski M; for the ION-4 Investigators: Ledipasvir and Sofosbuvir for HCV in Patients Coinfected with HIV-1. New England Journal of Medicine 373(8): 705-713, August 2015.

Papasavvas E, Foulkes A, Yin X, Joseph J, Ross B, Azzoni L, Kostman JR, Mounzer K, Shull J, Montaner LJ: Plasmacytoid dendritic cell and functional HIV Gag p55-specific T cells before treatment interruption can inform set-point plasma HIV viral load after treatment interruption in chronically suppressed HIV-1(+) patients. Immunology 145(3): 380-390, July 2015.

Yehia BR, Stewart L, Momplaisir F, Mody A, Holtzman CW, Jacobs LM, Hines J, Mounzer K, Glanz K, Metlay JP, Shea JA: Barriers and facilitators to patient retention in HIV care. BMC Infectious Diseases Page: 246, June 2015.

Holtzman CW, Shea JA, Glanz K, Jacobs LM, Gross R, Hines J, Mounzer K, Samuel R, Metlay JP, Yehia BR: Mapping patient-identified barriers and facilitators to retention in HIV care and antiretroviral therapy adherence to Andersen's Behavioral Model. AIDS Care Page: 1-12, February 2015.

Patro S, Pal S, Bi Y, Lynn K, Mounzer K, Kostman J, Davuluri R, Montaner LJ: Shift in Monocyte Apoptosis with Increasing Viral Load and Change in Apoptosis-related ISG/Bcl2-family Gene Expression in Chronic HIV-1 Infected Subjects Journal of Virology 89(1): 799-810, January 2015.

Kapalko A,Lalley-Chareczko L, Fibbi M, Mounzer K: Evaluation of an Integrated HIV/HCV Care Model in an Urban, Low-Income, HIV/HCV Co-Infection Clinic. American Association for the Study of Liver Diseases (AASLD)The Liver Meeting 2015 2015 Notes: Poster presentation.

Castagna A, Maggiolo F, Penco G, Wright D, Mills A,Grossberg R, Molina JM, Chas J, Durant J, Moreno S, Doroana M, Ait-Khaled M, Huang J, Min S,Song I, Vavro C, Nichols G, Yeo JM, for the VIKING-3 Study Group (72 collaborators) Aberg J, Akil B, Arribas JR, Baril JG, Blanco Arévalo JL, Blanco Quintana F, Blick G, Boix Martínez V, Bouchaud O, Branco T, Bredeek UF, Castro Iglesias M, Clumeck N, Conway B, DeJesus E, Delassus JL, De Truchis P, Di Perri G, Di Pietro M, Duggan J, Duvivier C, Elion R, Eron J, Fish D, Gathe J, Haubrich R, Henderson H, Hicks C, Hocqueloux L, Hodder S, Hsiao CB, Katlama C, Kozal M, Kumar P, Lalla-Reddy S, Lazzarin A, Leoncini F, Llibre JM, Mansinho K, Morlat P, Mounzer K: Dolutegravir in Antiretroviral-Experienced Patients With Raltegravir- and/or Elvitegravir-Resistant HIV-1: 24-Week Results of the Phase III VIKING-3 Study J Infect Dis Page: 354-62, August 2014.

back to top
Last updated: 02/02/2016
The Trustees of the University of Pennsylvania